The selective glucocorticoid receptor agonist mapracorat displays a favourable safety-efficacy ratio for the topical treatment of inflammatory skin diseases in dogs

2016 ◽  
Vol 28 (1) ◽  
pp. 46-e11 ◽  
Author(s):  
Wolfgang Bäumer ◽  
Kristine Rossbach ◽  
Bernard H. Schmidt
Keyword(s):  
Glucocorticoid Receptor ◽  
Topical Treatment ◽  
Receptor Agonist ◽  
Skin Diseases ◽  
Inflammatory Skin Diseases ◽  
Favourable Safety ◽  
Inflammatory Skin

scholarly journals JAK3 as an Emerging Target for Topical Treatment of Inflammatory Skin Diseases

PLoS ONE ◽  
2016 ◽  
Vol 11 (10) ◽  
pp. e0164080 ◽  
Author(s):  
Ana Karina Alves de Medeiros ◽  
Reinhart Speeckaert ◽  
Eline Desmet ◽  
Mireille Van Gele ◽  
Sofie De Schepper ◽  
...  
Keyword(s):  
Topical Treatment ◽  
Skin Diseases ◽  
Inflammatory Skin Diseases ◽  
Inflammatory Skin

Macrolactam immunomodulators for topical treatment of inflammatory skin diseases

2001 ◽  
Vol 45 (5) ◽  
pp. 736-743 ◽  
Author(s):  
Elke Bornhövd ◽  
Walter H.C. Burgdorf ◽  
Andreas Wollenberg
Keyword(s):  
Topical Treatment ◽  
Skin Diseases ◽  
Inflammatory Skin Diseases ◽  
Inflammatory Skin

scholarly journals Drug Delivery Systems for Topical treatment of Inflammatory Skin Diseases

2021 ◽  
Vol 5 (1) ◽  
pp. 59-64
Author(s):  
Shadeed Gad ◽  
Mohamed Desoqi ◽  
Hossam El-Sawy ◽  
Elsayed Khafagy ◽  
Mamdouh Ghourab
Keyword(s):  
Drug Delivery ◽  
Topical Treatment ◽  
Drug Delivery Systems ◽  
Skin Diseases ◽  
Delivery Systems ◽  
Inflammatory Skin Diseases ◽  
Inflammatory Skin
Sign in / Sign up

Export Citation Format

Share Document